Penalty Amount
$7,400,000,000
Texas Attorney General Ken Paxton announced the effective date of a $7.4 billion settlement with Purdue Pharma, Inc. and the Sackler family over their role in fueling the opioid crisis. Texas will receive $286.5 million from the settlement, bringing the state’s total opioid recovery funds to over $3 billion. The settlement includes permanent bans on Sackler opioid sales in the U.S., public release of 30 million company documents, and distribution of funds for addiction treatment and prevention over 15 years.
The $7.4 billion settlement requires Purdue and the Sacklers to pay out funds over several years, with Texas receiving $286.5 million. The Sackler family is permanently barred from selling opioids in the United States. Purdue’s manufacturing operations are transferred to Knoa Pharma LLC, which is prohibited from marketing opioids and overseen by an independent monitor to prevent prescription opioid diversion. Over 30 million documents related to Purdue’s opioid business will be made public, and settlement funds will be distributed to states, communities, and individual victims over 15 years for addiction treatment, prevention, and recovery programs.
This enforcement action pertains to opioid manufacturing and marketing violations, with no privacy or data protection components. As such, there are no privacy-related contract clauses (e.g., data processing, breach notification, consent) that require review based on this action. In-house teams should instead refer to opioid-related regulations for relevant contract reviews, which are outside the scope of this privacy-focused extraction.
Entity
Purdue Pharma, Inc. and the Sackler Family
Industry
Healthcare"Purdue Pharma, Inc. (“Purdue”) and its owners, the Sackler family"
"a $7.4 billion settlement with Purdue Pharma, Inc. (“Purdue”) and its owners, the Sackler family"
"Texas is expected to receive $286.5 million from the settlement"
"settlement"
"Attorney General Ken Paxton"
"coalition of 55 states and territories"
Texas Attorney General Ken Paxton launched an investigation into the American Academy of Pediatrics (AAP) over concerns that the organization may be promoting and recommending childhood vaccines for financial gain. The AAP has been issued a Civil Investigative Demand to determine the basis of its vaccine recommendations and whether they are influenced by financial incentives from pharmaceutical donors.
Texas Attorney General Ken Paxton announced an investigation into major food manufacturers, including Frito Lay, Flora Food Group, and ACH Foods, over misleading 'heart healthy' labeling. The investigation will examine whether their advertising practices violate the Texas Deceptive Trade Practices Act by misrepresenting the health value of their products. Civil Investigative Demands have been issued to these companies.
Texas Attorney General Ken Paxton opened an investigation into Lone Star Pups, LLC for misleading consumers about the origin and veterinary care of puppies sold online. The company allegedly misrepresents breeder certifications and a '10 Year Health Guarantee' with restrictive fine print. The investigation focuses on potential violations of the Texas Deceptive Trade Practices Act.
Texas Attorney General Ken Paxton announced industry-wide investigations into feminine care and cosmetic product brands, including Tampax, Kotex, L., and LOLA, over potential deceptive trade practices related to undisclosed toxic chemicals and heavy metals in their products. The investigations focus on whether consumers were misled about product safety and ingredient composition under the Texas Deceptive Trade Practices Act.
Texas Attorney General Ken Paxton issued a consumer alert warning Texans about scams, fraudulent charities, and illegal price gouging related to severe flooding. The guidance provides resources for verifying charities and reporting suspected fraud or price gouging to the AG's office.
$150.0M
Texas Attorney General Ken Paxton secured a $150 million multistate settlement against 23andMe following a 2023 data breach that exposed genetic and personal data of 6.9 million consumers. The settlement resolves bankruptcy claims and requires enhanced data security, risk assessments, and an independent advisory board, with immediate recovery of $18 million from bankruptcy funds.